Workplace shock and anaphylaxis statistics infographic showing 5% U.S. lifetime anaphylaxis prevalence, 5 to 30 minute cardiac arrest window requiring immediate epinephrine, 37.3% ICU mortality for septic shock, OSHA not requiring epinephrine autoinjectors in standard first aid kits, and biphasic anaphylaxis risk requiring mandatory emergency transport even after apparent recovery.

Shock and Anaphylaxis in the Workplace: 40+ Statistics on Recognition, Response, and Prevention Through 2025

by
with no comment
Insights
VelSafe Insights
Shock and Anaphylaxis in the Workplace: 40+ Statistics on Recognition, Response, and Prevention Through 2025
Anaphylaxis sends an estimated 200,000 Americans to the emergency room each year. Up to 5% of the U.S. population has experienced it. Delayed or absent epinephrine is the most consistent risk factor for fatal anaphylaxis across all trigger types. Cardiac arrest from anaphylaxis typically occurs within 5 to 30 minutes of exposure. Septic shock carries ICU mortality rates of 30 to 50%. Yet OSHA does not require epinephrine autoinjectors in standard workplace first aid kits, and most workers at risk for anaphylaxis in occupational settings rely entirely on personally carried devices. This article compiles 40+ statistics on shock types, anaphylaxis incidence and fatality, the epinephrine timing imperative, and what employers need to know about their preparedness obligations through 2025.
40+ Statistics
Anaphylaxis Incidence Data
Epinephrine Timing Research
Septic Shock Mortality
5%
of the U.S. population has experienced anaphylaxis at some point in their lives – approximately 16 million Americans carry this lifetime risk into their workplaces
ScienceDirect / Journal of Allergy and Clinical Immunology, 2024
5-30 min
Window within which cardiac or respiratory arrest typically occurs after anaphylaxis onset. Delayed epinephrine is the most consistent modifiable risk factor for fatal outcomes
Turner et al.; FDA Nasus submission, November 2025
30-50%
ICU mortality rate range for septic shock in developed countries. Over 48 million sepsis cases occur globally each year, with sepsis responsible for approximately 20% of all deaths worldwide
MDPI Journal of Clinical Medicine, September 2025

Shock is not a single event – it is a category of life-threatening conditions in which the body fails to deliver adequate oxygen and nutrients to vital tissues. Its forms range from anaphylactic shock triggered by an allergic reaction, to hypovolemic shock from blood or fluid loss, to septic shock from overwhelming infection, to cardiogenic shock from cardiac failure. Each has a distinct mechanism, distinct presentation, and distinct first-response protocol. And each can kill in minutes.

In the workplace, anaphylaxis is the shock type most directly within an employer’s ability to prepare for: the triggers (insect venom, food allergens, latex, medications) are identifiable, the at-risk population is identifiable, and the first-line treatment (epinephrine) is a single injectable drug that, administered promptly, is highly effective. Yet OSHA does not require epinephrine autoinjectors in standard workplace first aid kits, most employers do not maintain site-level epinephrine, and the literature consistently identifies delayed epinephrine as the dominant modifiable risk factor for fatal anaphylaxis. This article compiles 40+ statistics on all major shock types, with emphasis on anaphylaxis incidence, fatality risk, the epinephrine timing window, and what the current regulatory framework requires – and does not require – of employers.

Editor's Choice: Key Shock and Anaphylaxis Statistics for 2024-25

200,000
Estimated annual ER visits in the U.S. due to anaphylaxis, with food reactions sending a patient to the ER every 10 seconds. Up to 1% of all hospitalizations involve anaphylaxis. (FoodAllergy.org; Allergy and Asthma Network, 2024)
$33B
Annual direct medical costs of anaphylaxis in 2024, in CPI-adjusted dollars – making it one of the most economically significant acute allergic conditions in the U.S. healthcare system. (Allergy and Asthma Network, 2024)
49.6%
of anaphylaxis patients in a major Turkish study received epinephrine – meaning more than half did not, despite it being the universally recommended first-line treatment. This pattern is broadly consistent with U.S. emergency data. (World Allergy Organization Journal, January 2025)
Not required
OSHA’s standard workplace first aid kit contents (per 29 CFR 1910.266 App. A) do not include epinephrine autoinjectors. Employers who opt to add them are advised to seek legal counsel first regarding liability. (OSHA.gov; CCOHS)
Biphasic
Anaphylaxis can be biphasic – meaning a second wave of symptoms can occur 1 to 72 hours after apparent recovery, without re-exposure to the allergen. Workers who appear to have recovered must still be transported for medical evaluation. (JACI Dribin et al., 2025)
37.3%
ICU mortality rate for septic shock in European and North American ICUs (meta-analysis, Springer Nature 2019), consistent with the 30-50% range reported in the 2025 narrative ICU burden review. Hospital mortality is 39%. (Springer Nature Critical Care; MDPI JCM, 2025)

1. Types of Shock: Four Categories, Four Mechanisms

The Four Major Categories of Shock: Mechanism, Presentation, First Response
Anaphylactic
Mechanism: Severe allergic reaction causing widespread vasodilation, airway constriction, and fluid shifts. Triggers: food, insect venom, medications, latex. First response: epinephrine immediately, call 911, position supine, second dose if no improvement within 5-15 minutes.
Hypovolemic
Mechanism: Loss of blood or fluids reducing circulating volume below what tissues need. Causes: hemorrhage, severe burns, dehydration, crush injuries. First response: control bleeding, lay flat with legs elevated 12 inches, keep warm, call 911, do not give fluids by mouth.
Septic
Mechanism: Dysregulated immune response to infection causing systemic inflammation, vascular leakage, and organ dysfunction. Requires hospital treatment with IV antibiotics, vasopressors, and ICU support. First response: call 911 immediately, note signs of infection and timeline.
Cardiogenic
Mechanism: Heart failure to pump adequately, most commonly from myocardial infarction. Presentation: chest pain, shortness of breath, pale or clammy skin, weak pulse. First response: call 911 immediately, CPR if cardiac arrest, AED if available and indicated.
Sources: OSHA first aid guidance; American Heart Association; existing clinical literature
  • The four major shock categories share a common endpoint – inadequate tissue oxygenation – but have distinct mechanisms requiring distinct first responses. Treating anaphylactic shock with the first-aid protocols for hypovolemic shock (position flat, control bleeding) without administering epinephrine does not treat the underlying cause and allows anaphylaxis to progress. First-responder training must distinguish the categories. (clinical shock framework)
  • Neurogenic shock – caused by loss of sympathetic tone after spinal cord injury – is a fifth category relevant to workplaces with physical injury risks. It presents differently from other shock types: warm, flushed skin and paradoxical bradycardia (slow heart rate) despite hypotension, because the normal vasoconstriction and tachycardia response is absent. Misidentification leads to incorrect first response. (clinical neurology; trauma first aid)
  • All types of shock share recognizable general warning signs: pale, cold, or clammy skin; rapid and weak pulse; rapid and shallow breathing; confusion or altered mental status; weakness; and nausea. The presence of these signs in combination warrants immediate 911 activation regardless of the suspected type. (Red Cross; OSHA first aid guidance)

2. Anaphylaxis Incidence and Prevalence: How Common Is It?

1.6-5.1%
of U.S. citizens estimated to have experienced anaphylaxis in their lifetime (ScienceDirect 2024)
200,000
Estimated annual ER visits from anaphylaxis in the U.S. (FoodAllergy.org; Allergy Asthma Network)
Every 10 sec
A food allergy reaction sends a patient to the ER in the U.S. (FoodAllergy.org, 2024)
$33B
Annual direct medical costs of anaphylaxis in the U.S. (2024, CPI-adjusted) (Allergy Asthma Network)
  • Between 1.6% and 5.1% of U.S. citizens are estimated to have experienced anaphylaxis at some point in their lives. Upper-range estimates suggest up to 5% of the U.S. population – approximately 16 million people – carry this lifetime history into their workplaces and daily environments. (ScienceDirect / Journal of Allergy and Clinical Immunology; Fatal Anaphylaxis: Mortality Rate and Risk Factors, 2024)
  • Anaphylaxis is responsible for an estimated 200,000 emergency room visits per year in the U.S., with the Allergy and Asthma Network reporting $33 billion in annual direct medical costs in 2024 (CPI-adjusted dollars). Food allergy reactions alone send a patient to the ER every 10 seconds. (FoodAllergy.org, 2024; Allergy and Asthma Network, 2024)
  • More than 40% of children with food allergies have experienced a severe allergic reaction such as anaphylaxis, per FoodAllergy.org data (2024). This is relevant to workplaces because it establishes that a substantial share of the adult workforce has a prior anaphylaxis history and therefore elevated recurrence risk. (FoodAllergy.org, February 2024)
  • Insect venom is the dominant trigger in adults, accounting for approximately 50% of adult anaphylaxis cases in the European Anaphylaxis Registry (2014-2024), followed by medications (23%) and food (21%). In children, food is the dominant trigger (70%), followed by insects (16%) and medications (5.2%). The adult trigger distribution is directly relevant to outdoor workplace environments. (Anaphylaxis Registry 2014-2024; JACI, 2025)
  • Hospitalization rates for anaphylaxis have risen in recent years. 1% of all hospitalizations involve anaphylaxis, while 0.1% of all emergency department visits result in an anaphylaxis diagnosis. The incidence of fatal anaphylaxis has not increased proportionally, suggesting that medical care for anaphylaxis has improved – but the total burden of non-fatal events is growing. (ScienceDirect / JACI, 2024; Fatal Anaphylaxis review)

3. The Epinephrine Timing Imperative: Why Minutes Determine Outcomes

The Critical Window: Epinephrine Timing and Anaphylaxis Outcomes
0-5 min
Symptoms begin after allergen exposure. Most deaths from anaphylaxis involve symptoms developing within 5 minutes of allergen contact. Recognition within this window determines response timing.
5-30 min
Cardiac or respiratory arrest typically occurs within this window in fatal cases. Epinephrine administered before arrest has a dramatically higher success rate than post-arrest administration.
Under 5 min
Target window for epinephrine administration. Nasus intranasal epinephrine achieves therapeutic plasma levels within approximately 5 minutes. Standard autoinjectors provide intramuscular delivery. Both are far faster than waiting for EMS.
30 min (EMS avg)
Average EMS response time in many workplace and outdoor settings – well outside the therapeutic window for severe anaphylaxis. This gap is exactly why workplace-accessible epinephrine matters for at-risk employees.
Sources: Turner et al. global mortality analysis; FDA Nasus submission (November 2025); FoodAllergy.org guidelines
  • Turner et al.’s global analysis of fatal anaphylaxis mortality patterns found that delayed or absent epinephrine use was the most consistent risk factor across food, drug, and venom triggers. Fatal reactions typically progress to respiratory or cardiac arrest within 5 to 30 minutes of exposure – well before slower-acting responses can take effect. (Turner et al.; FDA Nasus submission, November 30, 2025)
  • Among patients who died from food-induced anaphylaxis in a key cohort study, only two received epinephrine in the first hour. All patients who survived had symptoms within 5 minutes of allergen ingestion, and all but one received epinephrine within 30 minutes. The retrospective survival pattern confirms that epinephrine timing is the key variable. (FDA Nasus submission, November 2025, citing original cohort data)
  • A real-world analysis using C-CARE data found that pre-hospital epinephrine was associated with lower odds of uncontrolled reactions, less IV fluid use in the ED, and fewer hospital admissions. The study authors explicitly stated that delaying epinephrine or not giving it before arrival is a risk factor for more severe or uncontrolled reactions. (Colli et al., cited in FDA Nasus submission, November 2025)
  • The 2024 GA2LEN consensus report on anaphylaxis management (published January 27, 2025 in JACI) reaffirmed that “immediate therapy with epinephrine is unanimously recommended to prevent death or serious complications.” No alternative first-line treatment is recognized. Antihistamines and corticosteroids are adjunct treatments only, not substitutes. (Dribin et al., JACI, January 27, 2025)
  • Biphasic anaphylaxis – in which a second wave of symptoms occurs 1 to 72 hours after apparent recovery, without re-exposure to the allergen – occurs in a clinically significant percentage of cases. The 2025 multidisciplinary Delphi study by Dribin et al. addressed biphasic, refractory, and protracted anaphylaxis specifically. Workers who appear to recover from anaphylaxis in the workplace must still be transported for medical evaluation – apparent recovery is not a reason to forego emergency care. (Dribin et al., JACI, August 2020; 2025 consensus update)

4. Anaphylaxis Triggers and Risk Factors: What Workplaces Need to Know

Insect Venom (Outdoor Workers)
50% of adult anaphylaxis cases in European registry. Hymenoptera stings (bees, wasps, hornets, yellow jackets). Highest risk: landscaping, agriculture, construction, utility, parks and recreation, and other outdoor occupations. Sensitivity can develop after prior exposures.
Medications (Healthcare Settings)
23% of adult anaphylaxis triggers. Beta-lactam antibiotics, general anesthetics, NSAIDs, and radiocontrast agents are most common. Healthcare, dental, and pharmaceutical workers face occupational exposure risk. Prior cardiovascular disease increases mortality risk from drug anaphylaxis.
Food (Food Industry and Catering)
21% of adult triggers; 70% in children. Food service, catering, food manufacturing, and school environments carry elevated occupational risk. Peanuts, tree nuts, shellfish, milk, and eggs are most common. Most fatal food anaphylaxis occurs in people with known food allergy.
Latex (Healthcare and Industrial)
Natural rubber latex allergy can cause anaphylaxis in healthcare workers and patients. Particularly relevant for surgical, dental, and laboratory environments. Latex-free workplace programs are standard in high-risk healthcare settings.
  • Outdoor workers in landscaping, agriculture, construction, and utilities face the highest occupational anaphylaxis risk from insect venom. Workers with a known history of severe reactions to insect stings should carry an epinephrine autoinjector, wear medical identification, and inform their supervisor, per OSHA’s insect sting safety guidance. (OSHA publication OSHA4137; CCOHS)
  • Fatal drug-induced anaphylaxis is more likely in individuals with prior cardiovascular morbidity and older age. As the median age of the U.S. workforce increases and workers with pre-existing cardiovascular conditions remain employed longer, the risk profile of drug anaphylaxis in healthcare and industrial settings grows. (ScienceDirect fatal anaphylaxis review, 2024)
  • The 2025 update to the Anaphylaxis Registry data (2014-2024) found that insect venom triggers have shown an increasing frequency in adults in the last two years, with researchers noting that climate change and other factors may affect insect population distribution and exposure patterns – an occupational safety implication for outdoor worker risk assessment. (Anaphylaxis Registry 2014-2024, NCBI PMC, 2025)
  • Asthma significantly increases the risk of fatal anaphylaxis. A major Turkish study found that the presence of asthma was significantly associated with fatal anaphylaxis outcomes (p less than 0.001) alongside older age and ICU hospitalization. Workers with documented asthma who also have known allergen sensitivities represent an elevated-risk population requiring specific emergency planning. (World Allergy Organization Journal, January 2025)
  • In adults, anaphylaxis of unknown trigger accounts for a substantial proportion of cases – 79.9% in the Turkish national database. This means that many workers who will experience workplace anaphylaxis have never been formally diagnosed with a specific allergy. First aid programs that require employees to disclose prior allergy diagnoses before making emergency preparations will miss the majority of the at-risk population. (World Allergy Organization Journal, January 2025)

5. Septic Shock: Incidence, Mortality, and Workplace Relevance

48M+
Global sepsis cases per year; 11 million deaths annually; 20% of all global mortality
MDPI JCM, September 2025
37.3%
ICU mortality rate for septic shock in N. America and Europe (Springer Nature meta-analysis)
Critical Care, 2019
39.0%
Hospital mortality rate for septic shock (same meta-analysis); 28-day mortality 36.7%
Critical Care, 2019
10.4%
of ICU admissions diagnosed with septic shock on arrival (Springer Nature meta-analysis)
Critical Care, 2019
  • Sepsis – defined as life-threatening organ dysfunction caused by a dysregulated host response to infection – accounts for approximately 11 million deaths per year globally, representing approximately 20% of all global mortality. Septic shock is the most severe form, in which circulatory and cellular dysfunction substantially increases mortality. (GBD 2021; MDPI Journal of Clinical Medicine, September 23, 2025)
  • A Springer Nature meta-analysis of European and North American ICU data found ICU mortality of 37.3%, hospital mortality of 39.0%, and 28-day/30-day mortality of 36.7% for septic shock patients. Significant between-study heterogeneity was noted, reflecting variation in patient populations, diagnostic criteria, and resource availability. (Springer Nature Critical Care, 2019; consistent with MDPI 2025 review range of 30-50%)
  • The workplace relevance of septic shock is indirect but significant. Workplace injuries that involve wound contamination, deep tissue damage, burns, or punctures can progress to infection and sepsis if wound care is inadequate or delayed. Workers in agricultural, waste management, and construction environments face the highest occupational exposure to wound-contaminating organisms. (occupational health framework)
  • Early identification is the critical survival determinant for septic shock. The Surviving Sepsis Campaign’s one-hour bundle – measure lactate, obtain blood cultures, administer broad-spectrum antibiotics, give IV crystalloids, apply vasopressors – is the evidence-based framework for in-hospital response. For workplaces, early recognition of sepsis warning signs and immediate EMS activation is the first-responder equivalent. (Surviving Sepsis Campaign; sepsis awareness literature)
  • SEP-1 bundle adherence in the U.S. hospital system has improved in recent years, but studies show substantial variation. A 2024 prehospital study found that prehospital National Early Warning Score (NEWS-2) of 7 or higher was associated with a 2.34-fold increase in in-hospital mortality for septic shock patients – confirming that prehospital identification tools have predictive value that EMS workers and first responders can act on. (Jouffroy et al., February 2024)

6. Hypovolemic Shock in the Workplace: Hemorrhage, Burns, and Fluid Loss

Hemorrhagic (Most Common)
Loss of 15-30% of blood volume (Class II) produces tachycardia and anxiety. Loss of 30-40% (Class III) produces confusion and significant drop in blood pressure. Greater than 40% loss (Class IV) is immediately life-threatening. Workplace hemorrhage from machinery, lacerations, and falls is the primary context.
Burns and Fluid Loss
Severe burns cause massive fluid shifts as plasma leaks from damaged blood vessels. Burns affecting more than 15-20% of total body surface area carry hypovolemic shock risk. Chemical burns in industrial settings and flame exposure in fire-adjacent occupations are the primary workplace contexts.
First Aid Response
Control external bleeding immediately with direct pressure. Do not remove impaled objects. Position supine with legs elevated 12 inches unless spinal injury is suspected. Keep the victim warm. Call 911. Do not give fluids by mouth – aspiration risk in unconscious or semi-conscious patients.
  • Hypovolemic shock from workplace hemorrhage is the most immediately controllable shock type through first aid intervention. Direct pressure applied within the first few minutes of severe bleeding can prevent progression to hypovolemic shock. Tourniquets for extremity hemorrhage, when applied correctly within the first few minutes, are life-saving for severe limb injuries. (Stop the Bleed program; OSHA first aid guidance)
  • The 2015-2022 period saw widespread adoption of the Stop the Bleed program, which teaches tourniquet application and wound packing to lay responders. OSHA’s first aid guidance for high-hazard industries increasingly references hemorrhage control as a core first aid competency beyond standard first aid certification. (Stop the Bleed; OSHA guidance)
  • Heat-related hypovolemic shock from extreme dehydration is a workplace-specific variant relevant to outdoor workers, construction workers, agricultural workers, and industrial employees working in high-heat environments. OSHA’s heat illness prevention standard addresses this risk through acclimatization, hydration protocols, and recognition training. (OSHA heat illness prevention; OSHA General Duty Clause)

7. Employer Preparedness: OSHA Requirements and the Epinephrine Gap

OSHA’s Anaphylaxis Framework: What Is and Is Not Required
Required: First Aid Access
29 CFR 1910.151 requires adequate first aid supplies and trained personnel be available. Where a hospital or clinic is not reasonably accessible, a person trained in first aid must be present. This is the primary employer obligation for shock response preparedness.
NOT Required: EpiPen in Kit
OSHA’s minimum required first aid kit contents (29 CFR 1910.266 App. A) do not include epinephrine autoinjectors. No OSHA standard mandates employers to maintain epinephrine at worksites. This is a material gap for at-risk workplaces.
Voluntary: Employer-Supplied EpiPen
Employers who choose to add epinephrine autoinjectors to their first aid kits are advised by CCOHS and CBIA to first seek legal counsel regarding liability. Several states have passed laws allowing entities (not just individuals) to maintain epinephrine on-site – check state law before implementing.
OSHA Recordability
Workplace anaphylaxis requiring ER transport and epinephrine administration is OSHA recordable under 29 CFR 1904. If the employee is hospitalized overnight, it is also OSHA reportable within 24 hours under 29 CFR 1904.39.
Sources: OSHA 29 CFR 1910.151; OSHA 29 CFR 1910.266 App. A; CCOHS; CBIA; Epostrix (May 2026)
  • OSHA’s general industry first aid standard (29 CFR 1910.151) requires that in the absence of an infirmary, clinic, or hospital near the workplace, a person trained in first aid must be available at the worksite. However, standard first aid training does not include epinephrine administration – creating a gap between the standard and the clinical requirement for anaphylaxis response. (OSHA 1910.151; CCOHS)
  • OSHA’s recommended approach for employers aware of workers with severe allergies: “If there is awareness of workers’ health conditions, first-aid products to address their needs should be on hand.” This language under 1910.151 guidance creates a practical, if not strictly mandatory, basis for maintaining epinephrine when at-risk workers are identified. (OSHA 1910.151 guidance; Workplace Material Handling and Safety, January 2024)
  • Workplace anaphylaxis requiring epinephrine administration and ER transport is OSHA recordable under 29 CFR 1904 as an illness with days away from work if applicable. If the employee is hospitalized overnight, it is OSHA reportable within 24 hours under 29 CFR 1904.39. An anaphylaxis event where an employee uses their own pre-existing personal EpiPen (prescribed before employment) may not be recordable depending on work-relatedness determination. (OSHA standard interpretation, September 13, 2018; Epostrix, May 2026)
  • The practical best practice for employers in high-risk environments: identify workers with known allergy histories during onboarding (voluntarily disclosed), ensure those workers carry prescribed epinephrine, ensure at least one first aid-trained employee on every shift knows the worker’s allergy status and device location, and have a written protocol for activating EMS. This does not require employer-supplied epinephrine to materially improve outcomes. (OSHA insect sting guidance; first aid program literature)

Key Takeaways for Safety Managers and First Aid Program Administrators

Epinephrine timing is the only modifiable factor that consistently determines fatal vs. non-fatal anaphylaxis outcomes
Turner et al.’s global mortality analysis found delayed or absent epinephrine to be the most consistent risk factor for fatal anaphylaxis across all trigger types. Cardiac arrest typically occurs within 5 to 30 minutes of exposure. EMS response in many workplace settings exceeds this window. The practical implication: at-risk workers must carry their own epinephrine, supervisors must know who those workers are, and the device must be accessible in seconds, not minutes.
5% of your workforce may have an anaphylaxis history – and most won’t have disclosed it
Up to 5% of the U.S. population has experienced anaphylaxis. The World Allergy Organization Journal 2025 study found 79.9% of anaphylaxis cases had an unknown trigger, meaning most people who will experience anaphylaxis have never been formally diagnosed with a specific allergy. First aid programs that only prepare for workers who have disclosed prior allergies will miss the majority of the at-risk population. Universal first-responder recognition training is the only approach that covers the actual risk population.
Apparent recovery is not recovery – biphasic anaphylaxis requires mandatory medical evaluation
Anaphylaxis can be biphasic: a second wave of symptoms can occur 1 to 72 hours after apparent resolution, without re-exposure. A worker who appears to have recovered after an anaphylactic episode must still be transported for medical evaluation. First aid protocols that allow a “wait and see” approach after apparent recovery create a serious liability and patient safety gap. Every anaphylaxis event at a workplace should result in 911 activation and transport regardless of apparent symptom resolution.
OSHA does not require epinephrine in first aid kits – but its guidance creates a practical obligation when at-risk workers are known
The minimum OSHA first aid kit contents do not include epinephrine autoinjectors. However, OSHA’s 1910.151 guidance explicitly states that if there is awareness of workers’ health conditions, first-aid products to address their needs should be on hand. This creates a practical and arguably legal basis for maintaining epinephrine when at-risk employees have been identified. Employers who choose to add epinephrine should check state law (several states allow entity-level epinephrine) and consult legal counsel on liability frameworks before implementation.
Septic shock carries 37-39% hospital mortality – and it starts with injuries that workplaces can prevent
Septic shock is not a direct workplace injury – it is the downstream consequence of infections that can originate from workplace wounds. Agricultural, construction, and waste management environments involve wound-contaminating organisms. Prompt wound care, infection recognition, and early medical referral for wounds that show signs of infection are the workplace first-response chain that prevents septic shock from originating in occupational injuries.
Antihistamines are not a substitute for epinephrine – ever
The 2025 GA2LEN consensus report (Dribin et al., JACI January 2025) reaffirms that immediate epinephrine is the only unanimously recommended first-line treatment for anaphylaxis. Antihistamines (diphenhydramine, cetirizine) and corticosteroids are adjunct treatments that address secondary symptoms – they do not reverse the systemic vasodilation and airway constriction driving anaphylactic shock. First aid programs that teach antihistamines as the primary anaphylaxis response create a false sense of treatment while the condition progresses. Epinephrine first, EMS second, antihistamines as adjunct only.

Sources

Government and Regulatory Sources

Clinical and Research Sources

Add a Comment

Your email address will not be published. Required fields are marked *